|Articles|August 1, 2009

Inside Outsourcing November 2009

External Link - article-619429.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

When the Slack Runs Out: AI and the CRO Operating Model

ByJoanna Williams

August 21st 2026

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ByAmber Hill, PhD,Andy Studna, Senior Editor

August 21st 2026

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

ByAndy Studna, Senior Editor

August 21st 2026

© tippapatt - © tippapatt - stock.adobe.com

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

ByAndy Studna, Senior Editor

August 20th 2026

Where AI Has the Most Immediate Impact in Phase I Execution

ByAmber Hill, PhD,Andy Studna, Senior Editor

August 20th 2026

Inside Outsourcing November 2009

Related Content

When the Slack Runs Out: AI and the CRO Operating Model

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Where AI Has the Most Immediate Impact in Phase I Execution

Trending on Applied Clinical Trials Online

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

When the Slack Runs Out: AI and the CRO Operating Model

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Where AI Has the Most Immediate Impact in Phase I Execution

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment